Nautilus Biotechnology (NAUT) Cash from Financing Activities (2020 - 2026)

Nautilus Biotechnology (NAUT) has 7 years of Cash from Financing Activities data on file, last reported at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities rose 6038.89% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 41.88% YoY), and the FY2025 full-year result was $214000.0, down 81.29% from the prior year.
• Cash from Financing Activities rose to $1.1 million in Q1 2026, from $101000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $1.1 million in Q1 2026 to a low of $1000.0 in Q1 2023.
• A 5-year average of $212062.5 and a median of $137500.0 in 2022 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities sank 99.94% in 2022 and soared 24400.0% in 2024, its largest moves.
• Tracing NAUT's Cash from Financing Activities over 5 years: stood at $135000.0 in 2022, then soared by 87.41% to $253000.0 in 2023, then jumped by 73.91% to $440000.0 in 2024, then slumped by 77.05% to $101000.0 in 2025, then jumped by 994.06% to $1.1 million in 2026.
• Business Quant data shows NAUT's Cash from Financing Activities at $1.1 million in Q1 2026, $101000.0 in Q4 2025, and $95000.0 in Q2 2025.